Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04313985 · ClinicalTrials.gov registry record · NA
Electrical Stimulation as an Adjunctive Therapy to Increase Vascular Perfusion in People With PAD or PVD
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04313985: Clinical Trial NA study, sponsored by Stanford University.
NCT04313985 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04313985, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to apply Avazzia micro-current stimulation to patients with chronic, non-healing wounds to determine if this therapy is effective in perfusion and bacterial measurements.
Primary Outcome
To compare wound tissue perfusion following treatment vs placebo (as measured using the HyperMed HyperView device)
Interventions
- DEVICE Tennant Biomodulator-Pro™ Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
Why NCT04313985 stopped before completion
NCT04313985 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Tennant Biomodulator-Pro™ Device is the first listed.
NCT04313985 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04313985 about?
NCT04313985 is a clinical study titled "Electrical Stimulation as an Adjunctive Therapy to Increase Vascular Perfusion in People With PAD or PVD". The purpose of this study is to apply Avazzia micro-current stimulation to patients with chronic, non-healing wounds to determine if this therapy is effective in perfusion and bacterial measurements.
What is the current status of trial NCT04313985?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-08-01. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04313985?
The interventions under investigation include: Tennant Biomodulator-Pro™ Device (DEVICE).
Who is sponsoring clinical trial NCT04313985?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04313985's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI